221 related articles for article (PubMed ID: 16127283)
1. Serotonin receptor 2A gene polymorphism (-1438A/G) and short-term treatment response to citalopram.
Choi MJ; Kang RH; Ham BJ; Jeong HY; Lee MS
Neuropsychobiology; 2005; 52(3):155-62. PubMed ID: 16127283
[TBL] [Abstract][Full Text] [Related]
2. Association between major depressive disorder and the -1438A/G polymorphism of the serotonin 2A receptor gene.
Choi MJ; Lee HJ; Lee HJ; Ham BJ; Cha JH; Ryu SH; Lee MS
Neuropsychobiology; 2004; 49(1):38-41. PubMed ID: 14730199
[TBL] [Abstract][Full Text] [Related]
3. Association between serotonin 2A receptor (HTR2A), serotonin transporter (SLC6A4) and brain-derived neurotrophic factor (BDNF) gene polymorphisms and citalopram/sertraline induced sexual dysfunction in MDD patients.
Oz MD; Baskak B; Uckun Z; Artun NY; Ozdemir H; Ozel TK; Ozguven HD; Suzen HS
Pharmacogenomics J; 2020 Jun; 20(3):443-450. PubMed ID: 31792367
[TBL] [Abstract][Full Text] [Related]
4. Effect of serotonin receptor 2A gene polymorphism on mirtazapine response in major depression.
Kang RH; Choi MJ; Paik JW; Hahn SW; Lee MS
Int J Psychiatry Med; 2007; 37(3):315-29. PubMed ID: 18314859
[TBL] [Abstract][Full Text] [Related]
5. The relationship between the serotonin 2A receptor gene -1438A/G and 102T/C polymorphisms and citalopram/sertraline-induced nausea in major depressed patients.
Demirbugen Oz M; Uckun Z; Yuce-Artun N; Baskak B; Ozdemir H; Kizil Ozel T; Devrimci Ozguven H; Suzen HS
Hum Psychopharmacol; 2018 Sep; 33(5):e2673. PubMed ID: 30221791
[TBL] [Abstract][Full Text] [Related]
6. Association between -1438G/A promoter polymorphism in the 5-HT(2A) receptor gene and fluvoxamine response in Japanese patients with major depressive disorder.
Sato K; Yoshida K; Takahashi H; Ito K; Kamata M; Higuchi H; Shimizu T; Itoh K; Inoue K; Tezuka T; Suzuki T; Ohkubo T; Sugawara K; Otani K
Neuropsychobiology; 2002; 46(3):136-40. PubMed ID: 12422060
[TBL] [Abstract][Full Text] [Related]
7. Brain-derived neurotrophic factor gene polymorphism (Val66Met) and citalopram response in major depressive disorder.
Choi MJ; Kang RH; Lim SW; Oh KS; Lee MS
Brain Res; 2006 Nov; 1118(1):176-82. PubMed ID: 16979146
[TBL] [Abstract][Full Text] [Related]
8. HTR2A-1438A/G polymorphism influences the risk of schizophrenia but not bipolar disorder or major depressive disorder: a meta-analysis.
Gu L; Long J; Yan Y; Chen Q; Pan R; Xie X; Mao X; Hu X; Wei B; Su L
J Neurosci Res; 2013 May; 91(5):623-33. PubMed ID: 23404241
[TBL] [Abstract][Full Text] [Related]
9. Association between the tryptophan hydroxylase-1 gene A218C polymorphism and citalopram antidepressant response in a Korean population.
Ham BJ; Lee BC; Paik JW; Kang RH; Choi MJ; Choi IG; Lee MS
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):104-7. PubMed ID: 16979275
[TBL] [Abstract][Full Text] [Related]
10. No relationship found between -1438A/G polymorphism of the serotonin 2A receptor gene (rs6311) and major depression susceptibility in a northeastern Thai population.
Tencomnao T; Thongrakard V; Phuchana W; Sritharathikhun T; Suttirat S
Genet Mol Res; 2010 Jun; 9(2):1171-6. PubMed ID: 20589614
[TBL] [Abstract][Full Text] [Related]
11. Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment.
McMahon FJ; Buervenich S; Charney D; Lipsky R; Rush AJ; Wilson AF; Sorant AJM; Papanicolaou GJ; Laje G; Fava M; Trivedi MH; Wisniewski SR; Manji H
Am J Hum Genet; 2006 May; 78(5):804-814. PubMed ID: 16642436
[TBL] [Abstract][Full Text] [Related]
12. TPH1, MAOA, serotonin receptor 2A and 2C genes in citalopram response: possible effect in melancholic and psychotic depression.
Arias B; Fabbri C; Gressier F; Serretti A; Mitjans M; Gastó C; Catalán R; De Ronchi D; Fañanás L
Neuropsychobiology; 2013; 67(1):41-7. PubMed ID: 23221997
[TBL] [Abstract][Full Text] [Related]
13. Association between serotonin transporter-linked polymorphic region and escitalopram antidepressant treatment response in Korean patients with major depressive disorder.
Won ES; Chang HS; Lee HY; Ham BJ; Lee MS
Neuropsychobiology; 2012; 66(4):221-9. PubMed ID: 23095326
[TBL] [Abstract][Full Text] [Related]
14. Association between T102C and A-1438G polymorphisms in the serotonin receptor 2A (5-HT2A) gene and schizophrenia: relevance for treatment with antipsychotic drugs.
Peñas-Lledó EM; Dorado P; Cáceres MC; de la Rubia A; Llerena A
Clin Chem Lab Med; 2007; 45(7):835-8. PubMed ID: 17617023
[TBL] [Abstract][Full Text] [Related]
15. Evidence for a combined genetic effect of the 5-HT(1A) receptor and serotonin transporter genes in the clinical outcome of major depressive patients treated with citalopram.
Arias B; Catalán R; Gastó C; Gutiérrez B; Fañanás L
J Psychopharmacol; 2005 Mar; 19(2):166-72. PubMed ID: 15728438
[TBL] [Abstract][Full Text] [Related]
16. Genetic dysfunction of serotonin 2A receptor hampers response to antidepressant drugs: A translational approach.
Qesseveur G; Petit AC; Nguyen HT; Dahan L; Colle R; Rotenberg S; Seif I; Robert P; David D; Guilloux JP; Gardier AM; Verstuyft C; Becquemont L; Corruble E; Guiard BP
Neuropharmacology; 2016 Jun; 105():142-153. PubMed ID: 26764241
[TBL] [Abstract][Full Text] [Related]
17. TPH2 -703G/T SNP may have important effect on susceptibility to suicidal behavior in major depression.
Yoon HK; Kim YK
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Apr; 33(3):403-9. PubMed ID: 19162119
[TBL] [Abstract][Full Text] [Related]
18. Pharmacogenetics of citalopram-related side effects in children with depression and/or anxiety disorders.
Amitai M; Kronenberg S; Carmel M; Michaelovsky E; Frisch A; Brent D; Apter A; Chen A; Weizman A; Fennig S
J Neural Transm (Vienna); 2016 Nov; 123(11):1347-1354. PubMed ID: 27324805
[TBL] [Abstract][Full Text] [Related]
19. Association between a functional serotonin transporter promoter polymorphism and citalopram treatment in adult outpatients with major depression.
Hu XZ; Rush AJ; Charney D; Wilson AF; Sorant AJ; Papanicolaou GJ; Fava M; Trivedi MH; Wisniewski SR; Laje G; Paddock S; McMahon FJ; Manji H; Lipsky RH
Arch Gen Psychiatry; 2007 Jul; 64(7):783-92. PubMed ID: 17606812
[TBL] [Abstract][Full Text] [Related]
20. Genetic variation in the tryptophan hydroxylase 2 gene moderates depressive symptom trajectories and remission over 8 weeks of escitalopram treatment.
Su YA; Li JT; Dai WJ; Liao XM; Dong LC; Lu TL; Bousman C; Si TM
Int Clin Psychopharmacol; 2016 May; 31(3):127-33. PubMed ID: 26745768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
